CN103768233A - Drug for treating glaucoma - Google Patents

Drug for treating glaucoma Download PDF

Info

Publication number
CN103768233A
CN103768233A CN201210412080.2A CN201210412080A CN103768233A CN 103768233 A CN103768233 A CN 103768233A CN 201210412080 A CN201210412080 A CN 201210412080A CN 103768233 A CN103768233 A CN 103768233A
Authority
CN
China
Prior art keywords
radix
rhizoma
raw material
drug
concha haliotidis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210412080.2A
Other languages
Chinese (zh)
Inventor
陈栖雨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210412080.2A priority Critical patent/CN103768233A/en
Publication of CN103768233A publication Critical patent/CN103768233A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a drug for treating the glaucoma, which is prepared from the following raw materials by weight: 10-25 concha haliotidis, 20-30 roots of rehmannia, 15-35 semen cassiae, 10-30 bighead atractylodes rhizome, 20-35 radix sileris, 20-40 notopterygium roots, 20-40 buddleja officinalis and 3-10 herba asaricum radice. The drug uses main medicines of the notopterygium roots, the buddleja officinalis and the like and other auxiliary materials, which affect one another and have synergistic effects, so that the good effects of liver calming and nourishing, mild wind dispelling and eyesight impriving are taken, the drug has the treatment effects on the glaucoma, the raw materials are simple, the both symptoms and root causes are treated, the cost is low, and the taking is convenient.

Description

One is treated glaucomatous medicine
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to one and treat glaucomatous medicine.
Background technology
Glaucoma be a kind ofly fall ill rapidly, hazardness causes blind common difficult oculopathy greatly, at any time.Feature is exactly the tolerant degree of horizontal exceeding eyeball institute that intraocular pressure is interrupted or persistence raises and bring infringement to eyeball each several part tissue and visual function, cause optic atrophy, constriction of visual field, visual deterioration, the blind just time sooner or later, can be as blind as a bat at acute attack stage 24-48 hour.Glaucoma belongs to eyes sexually transmitted disease (STD) and becomes, can fall ill by eyes simultaneously, or a glance onset, secondary blindness.The glaucomatous medicament categories for the treatment of is numerous at present, for example publication number is: CN1436550, name are called the Chinese invention patent application of " a kind of Chinese medicine for the treatment of oculopathy and preparation method thereof ", Oleum sesami, Membrana Follicularis ovi, Moschus, Flos Carthami, Fel Ursi, Margarita, Scorpio, Scolopendra that drug main of the present invention will be made up of following component form, and manufacture drop through special process.Product of the present invention is from clinical observation, and Drug therapy of the present invention is in extensive range, not only can treat keratopathy, can also treat iridocyclitis, secondary glaucoma.Through the clinical practice of decades, observe its effective percentage 100%, cure rate 96%, remaining is 4% years old.For the feature of many intractable ophthalmics, the present invention mainly utilizes Chinese medicine configuration to form drop, in the multiple persistent ailment for the treatment of ophthalmology, has obtained optimum curative effect.Through Long-term Clinical Observation, nontoxic, have no side effect, do not produce drug resistance.
Summary of the invention
The technical problem to be solved in the present invention is to provide the glaucomatous medicine of a kind of with low cost, eutherapeutic treatment.
For solving the problems of the technologies described above, the present invention by the following technical solutions:
The present invention treats glaucomatous medicine, is to be made up of the raw material of following weight proportioning:
Concha Haliotidis 10~25, the Radix Rehmanniae 20~30, Semen Cassiae 15~35, the Rhizoma Atractylodis Macrocephalae 10~30, Radix Saposhnikoviae 20~35, Rhizoma Et Radix Notopterygii 20~40, Flos Buddlejae 20~40, Herba Asari 3~10.
The preferred weight proportioning of each raw material is:
Concha Haliotidis 15~20, the Radix Rehmanniae 22~28, Semen Cassiae 20~30, the Rhizoma Atractylodis Macrocephalae 12~25, Radix Saposhnikoviae 25~30, Rhizoma Et Radix Notopterygii 25~35, Flos Buddlejae 25~35, Herba Asari 4~8.
The optimum weight proportioning of each raw material is:
Concha Haliotidis 18, the Radix Rehmanniae 25, Semen Cassiae 25, the Rhizoma Atractylodis Macrocephalae 20, Radix Saposhnikoviae 28, Rhizoma Et Radix Notopterygii 30, Flos Buddlejae 30, Herba Asari 6.
The preparation method that the present invention treats glaucomatous medicine is: take by weight ratio raw material Concha Haliotidis, the Radix Rehmanniae, Semen Cassiae, the Rhizoma Atractylodis Macrocephalae, Radix Saposhnikoviae, Rhizoma Et Radix Notopterygii, Flos Buddlejae, Herba Asari, add the decocting of 8~15 times of raw material weights to boil, after water boils, slow fire boils 30~60 minutes, leaches medicinal liquid, to obtain final product.
The present invention treats in glaucomatous formula:
Concha Haliotidis has calming liver and clearing heat, effect of improving eyesight removing nebula.
It is thirsty for Tianjin wound that the Radix Rehmanniae Radix Rehmanniae has YIN nourishing and the production of body fluid promoting effect, the effect that interior-heat is quenched one's thirst.
Semen Cassiae has the functions such as clearing away liver-fire, wind-damp dispelling, tonifying kidney and improving eyesight.
Stating in vain can invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis.
Rhizoma Et Radix Notopterygii can control affection of exogenous wind-cold, it is lossless to have a headache, mimeograph cold-damp numbness, edema due to wind pathogen edema, sore swollen toxin.
Flos Buddlejae has heat clearing away nourishing the liver, the effect of improving acuity of vision and removing nebula.
Herba Asari can dispel the wind, cold expelling, and row water, has one's ideas straightened out.
Radix Saposhnikoviae has expelling pathogenic wind from the body surface, removing dampness to relieve pain, effect that relieving convulsion is jerked surely.
The instructions of taking that the present invention treats glaucomatous medicine is: oral, every day three times, each serving 100~200 grams.
The present invention treats glaucomatous medicine take Rhizoma Et Radix Notopterygii, Flos Buddlejae etc. as principal agent, other accessory drugs of arranging in pairs or groups, they influence each other, synergism, thereby play good suppressing the hyperactive liver nourishing the liver, dispelling wind and relieving, YIN nourishing function of improving eyesight, glaucoma is had to good curative effect, and its raw material is simple, treating both the principal and secondary aspects of a disease, with low cost, taking convenience.
The specific embodiment
With embodiment, the invention will be further described below, but the present invention is not limited to these embodiment.
Umber described in following embodiment is weight portion.
Embodiment 1
Drug weight proportioning:
10 parts of Concha Haliotidis, 20 parts, the Radix Rehmanniae, 15 parts of Semen Cassiaes, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Radix Saposhnikoviaes, 20 parts of Rhizoma Et Radix Notopterygiis, 20 parts of Flos Buddlejaes, 3 parts of Herba Asaris.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 15 times of raw material weights to boil, after water boils, slow fire boils 60 minutes, leaches medicinal liquid, to obtain final product.
Embodiment 2
Drug weight proportioning:
25 parts of Concha Haliotidis, 30 parts, the Radix Rehmanniae, 35 parts of Semen Cassiaes, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 35 parts of Radix Saposhnikoviaes, 40 parts of Rhizoma Et Radix Notopterygiis, 40 parts of Flos Buddlejaes, 10 parts of Herba Asaris.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 8 times of raw material weights to boil, after water boils, slow fire boils 30 minutes, leaches medicinal liquid, to obtain final product.
Embodiment 3
Drug weight proportioning:
18 parts of Concha Haliotidis, 25 parts, the Radix Rehmanniae, 25 parts of Semen Cassiaes, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 28 parts of Radix Saposhnikoviaes, 30 parts of Rhizoma Et Radix Notopterygiis, 30 parts of Flos Buddlejaes, 6 parts of Herba Asaris.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 10 times of raw material weights to boil, after water boils, slow fire boils 40 minutes, leaches medicinal liquid, to obtain final product.

Claims (4)

1. the glaucomatous medicine for the treatment of, it is characterized in that being made up of the raw material of following weight proportioning:
Concha Haliotidis 10~25, the Radix Rehmanniae 20~30, Semen Cassiae 15~35, the Rhizoma Atractylodis Macrocephalae 10~30, Radix Saposhnikoviae 20~35, Rhizoma Et Radix Notopterygii 20~40, Flos Buddlejae 20~40, Herba Asari 3~10.
2. the glaucomatous medicine for the treatment of according to claim 1, is characterized in that the weight proportion of each raw material is:
Concha Haliotidis 15~20, the Radix Rehmanniae 22~28, Semen Cassiae 20~30, the Rhizoma Atractylodis Macrocephalae 12~25, Radix Saposhnikoviae 25~30, Rhizoma Et Radix Notopterygii 25~35, Flos Buddlejae 25~35, Herba Asari 4~8.
3. the glaucomatous medicine for the treatment of according to claim 2, is characterized in that the weight proportion of each raw material is:
Concha Haliotidis 18, the Radix Rehmanniae 25, Semen Cassiae 25, the Rhizoma Atractylodis Macrocephalae 20, Radix Saposhnikoviae 28, Rhizoma Et Radix Notopterygii 30, Flos Buddlejae 30, Herba Asari 6.
4. according to the glaucomatous medicine for the treatment of described in claim 1,2 or 3, the preparation method that it is characterized in that it is: take by weight ratio raw material Concha Haliotidis, the Radix Rehmanniae, Semen Cassiae, the Rhizoma Atractylodis Macrocephalae, Radix Saposhnikoviae, Rhizoma Et Radix Notopterygii, Flos Buddlejae, Herba Asari, add the decocting of 8~15 times of raw material weights to boil, after water boils, slow fire boils 30~60 minutes, leach medicinal liquid, to obtain final product.
CN201210412080.2A 2012-10-25 2012-10-25 Drug for treating glaucoma Pending CN103768233A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210412080.2A CN103768233A (en) 2012-10-25 2012-10-25 Drug for treating glaucoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210412080.2A CN103768233A (en) 2012-10-25 2012-10-25 Drug for treating glaucoma

Publications (1)

Publication Number Publication Date
CN103768233A true CN103768233A (en) 2014-05-07

Family

ID=50561293

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210412080.2A Pending CN103768233A (en) 2012-10-25 2012-10-25 Drug for treating glaucoma

Country Status (1)

Country Link
CN (1) CN103768233A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104435609A (en) * 2014-11-22 2015-03-25 李任 Traditional Chinese medicine composition for treating glaucoma
CN104721471A (en) * 2015-04-01 2015-06-24 青岛云天生物技术有限公司 Traditional Chinese medicine composition for treating liver-kidney yin deficiency type primary open-angle glaucoma
CN104800490A (en) * 2015-04-18 2015-07-29 青岛辰达生物科技有限公司 Traditional Chinese medicine composition for treating open-angle glaucoma

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1323595A (en) * 2000-05-11 2001-11-28 朱卫国 Composite medicine for glaucoma

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1323595A (en) * 2000-05-11 2001-11-28 朱卫国 Composite medicine for glaucoma

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中医研究院广安门医院: "《韦文贵眼科临床经验选》", 31 October 1980, 人民卫生出版社 *
彭清华等: "原发性青光眼古今中医文献整理研究", 《辽宁中医药大学学报》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104435609A (en) * 2014-11-22 2015-03-25 李任 Traditional Chinese medicine composition for treating glaucoma
CN104721471A (en) * 2015-04-01 2015-06-24 青岛云天生物技术有限公司 Traditional Chinese medicine composition for treating liver-kidney yin deficiency type primary open-angle glaucoma
CN104800490A (en) * 2015-04-18 2015-07-29 青岛辰达生物科技有限公司 Traditional Chinese medicine composition for treating open-angle glaucoma

Similar Documents

Publication Publication Date Title
CN103800485A (en) Traditional Chinese medicine preparation for treating herpes simplex keratitis
CN106309611A (en) Plaster with effects of relaxing muscles and stimulating blood circulation
CN103768233A (en) Drug for treating glaucoma
CN102579991B (en) Traditional Chinese medicine composition for treating herpes simplex viral keratitis
CN103735790A (en) Traditional Chinese medicine composition for treating tinnitus
CN103432533B (en) Traditional Chinese medicine for treating perianal abscess
CN103301328A (en) Trigeminal neuralgia treatment medicine
CN103768244A (en) Drug for treating cataract
CN103610819B (en) Chinese medicinal composition for treating vernal keratoconjunctivitis due to pathogenic wind
CN102462819A (en) Chinese medicinal composition for treating otitis media
CN103610797B (en) Traditional Chinese medicine composition for treating keratoconjunctivitis due to congestion and excess of dampness-heat
CN103830513A (en) Traditional Chinese medicine preparation for treating primary glaucoma
CN103768353A (en) Drug for treating trachoma
CN103494986B (en) The Chinese medicine for the treatment of primary trigeminal neuralgia
CN1394624A (en) Chinese medicine prescription for curing eye disease and its preparation method
CN103623234B (en) Traditional Chinese medicine composition for treating blood deficiency engendering wind type vernal keratoconjunctivitis
CN104739948A (en) Traditional Chinese medicine for treating cold
CN103877433A (en) Chinese medicinal composition for treating arthritis and preparation method thereof
CN101890089A (en) Formula for treating periarthritis of shoulder and preparation method thereof
CN102940739A (en) Chinese medicinal composition for treating vernal keratoconjunctivitis
CN113144100A (en) Traditional Chinese medicine composition for treating facial paralysis, traditional Chinese medicine preparation and preparation method thereof
CN103446311A (en) Traditional Chinese medicine for treating trichomonas vaginitis
CN109419950A (en) A kind of Chinese medicine composition for treating trigeminal neuralgia
CN107982354A (en) A kind of Chinese medicinal effective-part composition for treating abdominal pain vomiting and diarrhoea and preparation method thereof
CN106474379A (en) A kind of Chinese medicine composition treating cat fever

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140507